These data indicate that CDK14 is a PTX-resistant marker and is regulated by the TGF-β signaling pathway. Targeting CDK14 to enhance the sensitivity of PTX may provide a new therapeutic strategy for reversing the PTX resistance in OC.
over 1 year ago
Journal
|
ABCB1 (ATP Binding Cassette Subfamily B Member 1) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CD14 (CD14 Molecule) • TGFB1 (Transforming Growth Factor Beta 1) • CDK14 (Cyclin Dependent Kinase 14) • SMAD2 (SMAD Family Member 2)
CDK14 overexpression partially rescued the inhibitory impact of miR-1-3p on OS cell growth. Overall, miR-1-3p inhibits OS cell proliferation and cell cycle progression while promoting cell apoptosis by targeting CDK14 and inactivating the Wnt/beta-catenin signaling.
CDK14, β-catenin, TCF4, and miR-26b form a positive feedback regulation to modulate pancreatic cancer cell phenotypes in vitro and tumor growth in vivo.